In this study, there were no statistically significant differences in the levels of the studied markers of endothelial function (TNF-α, IL-6, and IL-17A) between the OSA and non-OSA groups; however, SCD patients who displayed some of the symptoms suggestive of SDB had increased levels of the studied markers. The gene discussed is IL17A; the disease is sleep apnea syndrome.